Longitudinal alterations of executive function in non-psychotic adolescents at familial risk for schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 3, 2010, Pages 469-474

  Bhojraj, Tejas S ^a   Diwadkar, Vaibhav A ^b   Sweeney, John A ^c   Prasad, Konasale M ^d   Eack, Shaun M ^d   Montrose, Debra M ^d   Keshavan, Matcheri S ^a,b,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Attention; Executive function; Relatives; Schizophrenia

Indexed keywords

ARIPIPRAZOLE;

ADOLESCENT; ADULT; ARTICLE; ATTENTION; CHILD; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; GENETIC RISK; HIGH RISK POPULATION; HUMAN; INTELLIGENCE QUOTIENT; MALE; MENTAL PERFORMANCE; PERSEVERATION; PROSPECTIVE STUDY; SCHIZOPHRENIA; WISCONSIN CARD SORTING TEST;

ADOLESCENT; ANALYSIS OF VARIANCE; CHILD; EXECUTIVE FUNCTION; FAMILY HEALTH; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 77949657187     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.01.015     Document Type: Article

References (70)

1. Abdullaev Y., Bechtereva N., Melnichuk K. Neuronal activity of human caudate nucleus and prefrontal cortex in cognitive tasks. Behav Brain Res 1998, 97:159-177.
2. Bell M.D., Greig T.C., Kaplan E., Bryson G. Wisconsin Card Sorting Test dimensions in schizophrenia: factorial, predictive, and divergent validity. J Clin Exp Neuropsychol 1997, 19:933-941.
3. Berman I., Viegner B., Merson A., Allan E., Pappas D., Green A.I. Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia. Schizophr Res 1997, 25:1-10. DOI: S0920-9964(96)00098-9 [pii] 10.1016/S0920-9964(96)00098-9.
4. Birkett P., Sigmundsson T., Sharma T., Toulopoulou T., Griffiths T.D., Reveley A., et al. Executive function and genetic predisposition to schizophrenia-the Maudsley family study. Am J Med Genet B Neuropsychiatr Genet 2008, 147:285-293. 10.1002/ajmg.b.30594.
5. Bosia M., Anselmetti S., Pirovano A., Ermoli E., Marino E., Bramanti P., et al. HTTLPR functional polymorphism in schizophrenia: executive functions vs. sustained attention dissociation. Prog Neuropsychopharmacol Biol Psychiatry 2009, DOI: S0278-5846(09)00346-7 [pii] 10.1016/j.pnpbp.2009.10.001.
6. Bove E. Cognitive performance and basic symptoms in first-degree relatives of schizophrenic patients. Compr Psychiatry 2008, 49:321-329.
7. Byrne M., Hodges A., Grant E., Owens D.C., Johnstone E.C. Neuropsychological assessment of young people at high genetic risk for developing schizophrenia compared with controls: preliminary findings of the Edinburgh High Risk Study (EHRS). Psychol Med 1999, 29:1161-1173.
8. Caldu X., Vendrell P., Bartres-Faz D., Clemente I., Bargallo N., Jurado M.A., et al. Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects. Neuroimage 2007, 37:1437-1444. DOI: S1053-8119(07)00565-4 [pii] 10.1016/j.neuroimage.2007.06.021.
9. Chen E.Y., Lam L.C., Chen R.Y., Nguyen D.G., Chan C.K., Wilkins A.J. Neuropsychological correlates of sustained attention in schizophrenia. Schizophr Res 1997, 24:299-310. DOI: S092099649600120X [pii].
10. Corbetta M., Shulman G., Miezin F., Petersen S. Superior parietal cortex activation during spatial attention shifts and visual feature conjunction. Science 1995, 270:802.
11. Cornblatt B.A., Risch N.J., Faris G., Friedman D., Erlenmeyer-Kimling L. The Continuous Performance Test, identical pairs version (CPT-IP): I: new findings about sustained attention in normal families. Psychiatry Res 1988, 26:223-238. DOI: 0165-1781(88)90076-5 [pii].
12. DeLisi L.E. The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia. Schizophr Bull 2008, 34:312-321. DOI: sbm164 [pii] 10.1093/schbul/sbm164.
13. Dickinson D., Ragland J.D., Gold J.M., Gur R.C. General and specific cognitive deficits in schizophrenia: Goliath defeats David'. Biol Psychiatry 2008, 64:823-827. DOI: S0006-3223(08)00401-0 [pii] 10.1016/j.biopsych.2008.04.005.
14. Diwadkar V.A., Sweeney J.A., Boarts D., Montrose D.M., Keshavan M.S. Oculomotor delayed response abnormalities in young offspring and siblings at risk for schizophrenia. CNS Spectr 2001, 6:899-903.
15. Diwadkar V.A., Montrose D.M., Dworakowski D., Sweeney J.A., Keshavan M.S. Genetically predisposed offspring with schizotypal features: an ultra high-risk group for schizophrenia?. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30:230-238. DOI: S0278-5846(05)00318-0 [pii] 10.1016/j.pnpbp.2005.10.019.
16. Eack S.M., Prasad K.M., Montrose D.M., Goradia D.D., Dworakowski D., Miewald J., et al. An integrated psychobiological predictive model of emergent psychopathology among young relatives at risk for schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1873-1878. DOI: S0278-5846(08)00257-1 [pii] 10.1016/j.pnpbp.2008.08.024.
17. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 2001, 98:6917-6922. DOI: 10.1073/pnas.111134598 [pii].
18. Enomoto T., Floresco S.B. Disruptions in spatial working memory, but not short-term memory, induced by repeated ketamine exposure. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:668-675. DOI: S0278-5846(09)00084-0 [pii] 10.1016/j.pnpbp.2009.03.013.
19. Erlenmeyer-Kimling L., Squires-Wheeler E., Adamo U., Bassett A., Cornblatt B., Kestenbaum C., et al. The New York High-Risk Project. Psychoses and cluster A personality disorders in offspring of schizophrenic parents at 23years of follow-up. Arch Gen Psychiatry 1995, 52:857.
20. First M., Spitzer R., Williams J., Gibbon M. Structured clinical interview for DSM-IV (SCID) 1995, American Psychiatric Association, Washington, DC.
21. Franke P., Maier W., Hain C., Klingler T. Wisconsin Card Sorting Test: an indicator of vulnerability to schizophrenia?. Schizophr Res 1992, 6:243-249.
22. Fuller R., Nopoulos P., Arndt S., O'Leary D., Ho B., Andreasen N. Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance. Am J Psychiatry 2002, 159:1183-1189.
23. Gogtay N., Giedd J.N., Lusk L., Hayashi K.M., Greenstein D., Vaituzis A.C., et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A 2004, 101:8174-8179. DOI: 10.1073/pnas.0402680101 [pii].
24. Gold J.M., Rehkemper G., Binks S.W., Carpenter C.J., Fleming K., Goldberg T.E., et al. Learning and forgetting in schizophrenia. J Abnorm Psychology 2000, 109:534-538.
25. Goldberg T.E., Goldman R.S., Burdick K.E., Malhotra A.K., Lencz T., Patel R.C., et al. Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?. Arch Gen Psychiatry 2007, 64:1115-1122. DOI: 64/10/1115 [pii] 10.1001/archpsyc.64.10.1115.
26. Gooding D.C., Kwapil T.R., Tallent K.A. Wisconsin Card Sorting Test deficits in schizotypic individuals. Schizophr Res 1999, 40:201-209. DOI: S0920996499001243 [pii].
27. Gur R., Calkins M., Gur R., Horan W., Nuechterlein K., Seidman L., et al. The consortium on the genetics of schizophrenia: neurocognitive endophenotypes. Schizophr Bull 2007, 33:49.
28. Harrison P.J. Schizophrenia susceptibility genes and neurodevelopment. Biol Psychiatry 2007, 61:1119-1120. DOI: S0006-3223(07)00194-1 [pii] 10.1016/j.biopsych.2007.02.021.
29. Hartman M., Steketee M.C., Silva S., Lanning K., Andersson C. Wisconsin Card Sorting Test performance in schizophrenia: the role of working memory. Schizophr Res 2003, 63:201-217. DOI: S0920996402003535 [pii].
30. Heaton R., Chelune G., Talley J., Kay G., Curtiss G. Wisconsin Card Sorting Test manual: revised and expanded 1993, Psychological Assessment Resources, Odessa, FL.
31. Heaton R., Paulsen J.S., McAdams L.A., Kuck J., Zisook S., Braff D., et al. Neuropsychological deficits in schizophrenics. Relationship to age, chronicity, and dementia. Arch Gen Psychiatry 1994, 51:469-476.
32. Johnstone E., Ebmeier K., Miller P., Owens D., Lawrie S. Predicting schizophrenia: findings from the Edinburgh high-risk study. Br J Psychiatry 2005, 186:18-25.
33. Kawada R., Yoshizumi M., Hirao K., Fujiwara H., Miyata J., Shimizu M., et al. Brain volume and dysexecutive behavior in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:1255-1260. DOI: S0278-5846(09)00242-5 [pii] 10.1016/j.pnpbp.2009.07.014.
34. Keefe R., Silverman J., Roitman S., Harvey P., Duncan M., Alroy D., et al. Performance of nonpsychotic relatives of schizophrenic patients on cognitive tests. Psychiatry Res 1994, 53:1-12.
35. Keefe R.S., Silverman J.M., Roitman S.E., Harvey P.D., Duncan M.A., Alroy D., et al. Performance of nonpsychotic relatives of schizophrenic patients on cognitive tests. Psychiatry Res 1994, 53:1-12.
36. Keefe R.S., Perkins D.O., Gu H., Zipursky R.B., Christensen B.K., Lieberman J.A. A longitudinal study of neurocognitive function in individuals at-risk for psychosis. Schizophr Res 2006, 88:26-35. DOI: S0920-9964(06)00309-4 [pii] 10.1016/j.schres.2006.06.041.
37. Keshavan M., Diwadkar V., Montrose D., Stanley J., Pettegrew J. Premorbid characterization in schizophrenia: the Pittsburgh High Risk Study. World Psychiatry 2004;3:163-8.
38. Keshavan M.S., Montrose D.M., Pierri J.N., Dick E.L., Rosenberg D., Talagala L., et al. Magnetic resonance imaging and spectroscopy in offspring at risk for schizophrenia: preliminary studies. Prog Neuropsychopharmacol Biol Psychiatry 1997, 21:1285-1295. DOI: S0278584697001644 [pii].
39. Keshavan M.S., Diwadkar V.A., Spencer S.M., Harenski K.A., Luna B., Sweeney J.A. A preliminary functional magnetic resonance imaging study in offspring of schizophrenic parents. Prog Neuropsychopharmacol Biol Psychiatry 2002, 26:1143-1149. DOI: S0278-5846(02)00249-X [pii].
40. Keshavan M.S., Stanley J.A., Montrose D.M., Minshew N.J., Pettegrew J.W. Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo 31P MRS study. Mol Psychiatry 2003, 8:316-23, 251. DOI: 10.1038/sj.mp.4001325 [pii].
41. Keshavan M.S., Diwadkar V.A., Montrose D.M., Stanley J.A., Pettegrew J.W. Premorbid characterization in schizophrenia: the Pittsburgh High Risk Study. World Psychol 2004, 3:163-168.
42. Keshavan M.S., Kulkarni S., Bhojraj T., Francis A., Diwadkar V., Montrose D.M., et al. Premorbid cognitive deficits in young relatives of schizophrenia patients. Front Hum Nutr 2009, 3. 10.3389/neuro.09.062.2009.
43. Kremen W., Buka S., Seidman L., Goldstein J., Koren D., Tsuang M. IQ Decline during Childhood and Adult Psychotic Symptoms in a Community Sample: A 19-year Longitudinal Study 1998, 672-677. Am Psychiatric Assoc.
44. Krystal J.H., Bennett A., Abi-Saab D., Belger A., Karper L.P., D'Souza D.C., et al. Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions. Biol Psychiatry 2000, 47:137-143. DOI: S0006-3223(99)00097-9 [pii].
45. Lencz T., Smith C., McLaughlin D., Auther A., Nakayama E., Hovey L., et al. Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biol Psychiatry 2006, 59:863-871.
46. Levin H., Culhane K., Hartmann J., Evankovich K., Mattson A., Harward H., et al. Developmental changes in performance on tests of purported frontal lobe functioning. Dev Neuropsychol 1991, 7:377-395.
47. Liao S.Y., Lin S.H., Liu C.M., Hsieh M.H., Hwang T.J., Liu S.K., et al. Genetic variants in COMT and neurocognitive impairment in families of patients with schizophrenia. Genes Brain Behav 2009, 8:228-237. DOI: GBB467 [pii] 10.1111/j.1601-183X.2008.00467.x.
48. Lin C., Hsiao C., Chen W. Development of sustained attention assessed using the continuous performance test among children 6-15years of age. J Abnorm Child Psychol 1999, 27:403-412.
49. Liu Y.L., Fann C.S., Liu C.M., Chen W.J., Wu J.Y., Hung S.I., et al. RASD2, MYH9, and CACNG2 genes at chromosome 22q12 associated with the subgroup of schizophrenia with non-deficit in sustained attention and executive function. Biol Psychiatry 2008, 64:789-796. DOI: S0006-3223(08)00567-2 [pii] 10.1016/j.biopsych.2008.04.035.
50. Luna B., Thulborn K.R., Munoz D.P., Merriam E.P., Garver K.E., Minshew N.J., et al. Maturation of widely distributed brain function subserves cognitive development. Neuroimage 2001, 13:786-793. DOI: 10.1006/nimg.2000.0743 [pii] S1053-8119(00)90743-2.
51. Macdonald A.W., Thermenos H.W., Barch D.M., Seidman L.J. Imaging genetic liability to schizophrenia: systematic review of fMRI studies of patients' nonpsychotic relatives. Schizophr Bull 2008, DOI: sbn053 [pii] 10.1093/schbul/sbn053.
52. Maurice-Stam H., Oort F.J., Last B.F., Brons P.P., Caron H.N., Grootenhuis M.A. School-aged children after the end of successful treatment of non-central nervous system cancer: longitudinal assessment of health-related quality of life, anxiety and coping. Eur J Cancer Care (Engl) 2009, 18:401-410. DOI: ECC1041 [pii] 10.1111/j.1365-2354.2008.01041.x.
53. Meyer-Lindenberg A., Miletich R.S., Kohn P.D., Esposito G., Carson R.E., Quarantelli M., et al. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci 2002, 5:267-271. DOI: 10.1038/nn804 [pii].
54. Niendam T., Bearden C., Zinberg J., Johnson J., O'Brien M., Cannon T. The course of neurocognition and social functioning in individuals at ultra high risk for psychosis. Schizophr Bull 2007, 33:772.
55. Posner M.I., Dehaene S. Attentional networks. Trends Neurosci 1994, 17:75-79.
56. Prasad K.M., Keshavan M.S. Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"?. Schizophr Bull 2008, 34:774-790. DOI: sbn017 [pii] 10.1093/schbul/sbn017.
57. Quinones R.M., Calderin Y.C., Dominguez M., Bravo T.M., Berazain A.R., Garcia A., et al. Heritability of Trail Making Test performance in multiplex schizophrenia families: implications for the search for an endophenotype. Eur Arch Psychiatry Clin Neurosci 2009, 259:475-481. 10.1007/s00406-009-0012-6.
58. Rybakowski J.K., Borkowska A., Czerski P.M., Kapelski P., Dmitrzak-Weglarz M., Hauser J. An association study of dopamine receptors polymorphisms and the Wisconsin Card Sorting Test in schizophrenia. J Neural Transm 2005, 112:1575-1582. 10.1007/s00702-005-0292-6.
59. Shad M.U., Muddasani S., Prasad K., Sweeney J.A., Keshavan M.S. Insight and prefrontal cortex in first-episode schizophrenia. Neuroimage 2004, 22:1315-1320. DOI: 10.1016/j.neuroimage.2004.03.016 [pii]S1053811904001715.
60. Shad M.U., Tamminga C.A., Cullum M., Haas G.L., Keshavan M.S. Insight and frontal cortical function in schizophrenia: a review. Schizophr Res 2006, 86:54-70. DOI: S0920-9964(06)00274-X [pii] 10.1016/j.schres.2006.06.006.
61. Siegel B.V., Trestman R.L., O'Flaithbheartaigh S., Mitropoulou V., Amin F., Kirrane R., et al. D-amphetamine challenge effects on Wisconsin Card Sort Test. Performance in schizotypal personality disorder. Schizophr Res 1996, 20:29-32. DOI: 0920-9964(95)00002-X [pii].
62. Sowell E.R., Thompson P.M., Holmes C.J., Jernigan T.L., Toga A.W. In vivo evidence for post-adolescent brain maturation in frontal and striatal regions. Nat Neurosci 1999, 2:859-861. 10.1038/13154.
63. Sowell E.R., Thompson P.M., Holmes C.J., Batth R., Jernigan T.L., Toga A.W. Localizing age-related changes in brain structure between childhood and adolescence using statistical parametric mapping. Neuroimage 1999, 9:587-597. DOI: S1053-8119(99)90436-6 [pii] 10.1006/nimg.1999.0436.
64. Tomasi D., Wang R., Telang F., Boronikolas V., Jayne M., Wang G., et al. Impairment of attentional networks after 1 night of sleep deprivation. Cereb Cortex 2008.
65. Weickert T.W., Terrazas A., Bigelow L.B., Malley J.D., Hyde T., Egan M.F., et al. Habit and skill learning in schizophrenia: evidence of normal striatal processing with abnormal cortical input. Learn Mem 2002, 9:430-442. 10.1101/lm.49102.
66. Weinberger D.R., Egan M.F., Bertolino A., Callicott J.H., Mattay V.S., Lipska B.K., et al. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 2001, 50:825-844. S0006322301012525 [pii].
67. Whyte M., Brett C., Harrison L., Byrne M., Miller P., Lawrie S., et al. Neuropsychological performance over time in people at high risk of developing schizophrenia and controls. Biol Psychiatry 2006, 59:730-739.
68. Wobrock T., Ecker U.K., Scherk H., Schneider-Axmann T., Falkai P., Gruber O. Cognitive impairment of executive function as a core symptom of schizophrenia. World J Biol Psychiatry 2009, 10:442-451. 790041372 [pii]. 10.1080/15622970701849986.
69. Wolf L.E., Cornblatt B.A., Roberts S.A., Shapiro B.M., Erlenmeyer-Kimling L. Wisconsin Card Sorting deficits in the offspring of schizophrenics in the New York High-Risk Project. Schizophr Res 2002, 57:173. S0920996401003012 [pii].
70. Wood S., Pantelis C., Proffitt T., Phillips L., Stuart G., Buchanan J., et al. Spatial working memory ability is a marker of risk-for-psychosis. Psychol Med 2003, 33:1239-1247.